CStone Pharmaceuticals (HKG:2616)
Hong Kong · Delayed Price · Currency is HKD 7.81
+0.06 (0.77%)
May 27, 2026, 4:09 PM HKT
CStone Pharmaceuticals Market Cap
CStone Pharmaceuticals has a market cap or net worth of 12.48 billion as of May 27, 2026. Its market cap has increased by 217.17% in one year.
Market Cap
12.48B
Enterprise Value
11.80B
Revenue
299.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
7.81
Market Cap Chart
Since February 26, 2019, CStone Pharmaceuticals's market cap has decreased from 12.65B to 12.48B, a decrease of -1.37%. That is a compound annual growth rate of -0.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 26, 2026 | 12.39B | 59.46% |
| Dec 31, 2025 | 7.77B | 164.57% |
| Dec 31, 2024 | 2.94B | 1.52% |
| Dec 29, 2023 | 2.89B | -47.58% |
| Dec 30, 2022 | 5.52B | -42.71% |
| Dec 31, 2021 | 9.63B | -16.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Feb 26, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Keymed Biosciences | 17.82B |
| Zai Lab | 16.24B |
| TransThera Sciences (Nanjing) | 15.64B |
| Ascletis Pharma | 15.55B |
| Ascentage Pharma Group International | 14.52B |
| Nanjing Leads Biolabs | 12.42B |
| Everest Medicines | 10.87B |
| CARsgen Therapeutics Holdings | 10.35B |